Search Results for " Canagliflozin "
Canagliflozin Impurity 40
| SZ CAT No: | SZ-C010073 |
| CAS No | 2648415-13-6 |
| Mol.F. | C30H33FO11S |
| Mol.Wt. | 620.6 |
| Inv. Status | Custom Synthesis |
Additional Documents required to purchaseChemical Name: (2S,3S,4S,5R,6R)-6-(((2S,3S,4R,5R,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid
Shipping Temperature: Ambient
HSN Code: 38229010
Country of Origin: India
Smiles: O[C@H]1[C@H](C2=CC(CC3=CC=C(C4=CC=C(C=C4)F)S3)=C(C=C2)C)O[C@@H]([C@H]([C@@H]1O[C@@H]5O[C@@H]([C@H]([C@@H]([C@H]5O)O)O)C(O)=O)O)CO
Development and validation of HPLC method for determination of trace level potential genotoxic hydroperoxide impurity in canagliflozin
By Gosar, Amit; Shaikh, Tabrez; Botkondle, Suresh; Mahadik, Neelam; Tole, Rahul
From International Journal of Pharma Research and Health Sciences (2019), 7(5), 3068-3071
Bioanalytical method development and validation of canagliflozin in human plasma by liquid chromatography-tandem mass spectrometry
By Deepan, T.; Rao, M. V. Basaveswara; Dhanaraju, M. D.
From Asian Journal of Pharmaceutical and Clinical Research (2019), 12(8), 46-51
Analytical method development and validation of canagliflozin and metformin HCl by using RP - HPLC
By Bakshi, Anjali; Reddy, Ns; Bhutada, Shweta; Raju, M. Bhagvan
From International Journal of Pharmacy and Pharmaceutical Research (2018), 12(4), 122-130
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new development or finding in product specification without further noticed.